Clinical Trial Update: High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating high-dose interferon alfa for stage II or stage III melanoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (Intron A) (interferon alfa-2b)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Melanoma (Skin) | Phase 3 | Status: WITHDRAWN